How can we manage the cardiac toxicity of immune checkpoint inhibitors?
Dr. CG Tocchetti, et al.
Read MoreCardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors.
Dr. CG Tocchetti, et al.
Read MoreRedox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC).
Dr. CG Tocchetti, et al.
Read MoreCardiac dysfunction in cancer patients: beyond direct cardiomyocyte
damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart.
Dr. CG Tocchetti, et al.
Read More